Welcome to our dedicated page for ASTERA LABS SEC filings (Ticker: ALAB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Astera Labs filings document a Nasdaq-listed semiconductor connectivity company serving rack-scale AI infrastructure. The company’s Form 8-K reports cover quarterly and annual operating results, product and demand commentary tied to PCIe 6, Scorpio smart fabric switches, signal conditioning and Smart Cable Modules, and material business updates.
ALAB regulatory disclosures also record its common stock listing on the Nasdaq Global Select Market, emerging growth company status, executive officer appointments and compensation arrangements, and material definitive agreements, including customer-linked warrant terms. Proxy materials describe annual meeting proposals, board elections, auditor ratification, executive compensation votes and stockholder voting mechanics.
Astera Labs, Inc. General Counsel and Secretary Philip Mazzara reported an open-market sale of 796 shares of Common Stock on May 21, 2026, at an average price of $291.0251 per share. Following this transaction, he continues to hold 103,343 shares directly.
ALAB notice of proposed and recent sales of Common stock under Rule 144 by a related holder. The filing lists prior private acquisitions of 17,508 shares (03/21/2018) and 2,492 shares (09/11/2020) and reports four sales in May 2026: 49,665 shares (05/14/2026), 8,429 shares (05/20/2026), 20,000 shares (05/21/2026) and 30,000 shares (05/22/2026).
ALAB Form 144 submission reports a proposed sale of 30,000 common shares on 05/22/2026. The filing lists prior sales by TATE 1997 LIVING TRUST during the past three months: 20,000 shares on 05/21/2026, 8,429 shares on 05/20/2026, and 49,665 shares on 05/14/2026, with dollar amounts shown alongside each trade.
Astera Labs, Inc. director and President & COO Gajendra Sanjay reported pre-planned sales of common stock tied to his estate planning trusts. On May 19, 2026, three trusts labeled Trust 1, Trust 2, and Trust 3 sold a combined 280,000 shares of Astera Labs common stock in open-market transactions.
The sales were executed automatically under a Rule 10b5-1 trading plan adopted by Sanjay on December 2, 2025. Reported weighted average sale prices ranged from about $248.40 to $251.80 per share. Following these transactions, Trust 1 held 5,561,374 shares, Trust 2 held 615,000 shares, and Trust 3 held 615,000 shares, while Sanjay also held 1,435,857 shares directly.
ALAB reports insider stock dispositions. Philip Mazzara reported multiple common stock sales in Form 144 filings: 10,000 shares on 03/02/2026, 10,000 shares on 04/01/2026, and two sales on 05/18/2026 of 9,204 shares and 4,872 shares. The filing also lists 796 shares of restricted stock dated 11/15/2024.
ALAB filed a Form 144 notice reporting proposed sales of Common Stock by affiliated trusts through Morgan Stanley Smith Barney LLC. The notice lists multiple planned or completed 10b5-1 sales: 40,000 shares, 200,000 shares and repeat sales on 05/07/2026 and 05/19/2026. The filing identifies 400,000 shares associated with the seller entry and shows aggregate dollar amounts for individual trades in each row.
ALAB reported Form 144 activity disclosing sales of Common Stock by a related holder. The filing lists a 20,000 share lot described under the securities-to-be-sold section. It also records two recent transactions by TATE 1997 LIVING TRUST: 8,429 shares sold on 05/20/2026 for $2,290,075.01 and 49,665 shares sold on 05/14/2026 for $11,234,674.95.
Astera Labs, Inc. director and Chief Executive Officer Mohan Jitendra reported automatic sales of 95,444 shares of common stock. According to the disclosure, these shares were required to be sold to satisfy tax withholding obligations tied to the vesting and settlement of previously granted restricted stock units and were executed under a pre‑elected "sell to cover" arrangement, not as discretionary trades.
Following these transactions, he continues to hold 1,433,335 shares of common stock directly, along with additional indirect holdings through several estate planning and living trusts.
Astera Labs, Inc. President and COO Gajendra Sanjay reported automatic tax-related share sales. On 2026-05-18, Form 4 shows the sale of 95,444 shares of Astera Labs common stock in multiple open-market transactions at prices between $216.10 and $235.94 per share.
According to a footnote, these sales were required to satisfy tax withholding obligations arising from the vesting and settlement of previously granted restricted stock units and were executed under a pre-arranged “sell to cover” election, rather than as discretionary trades. Additional entries show large indirect holdings in three estate planning trusts, for which Sanjay disclaims beneficial ownership except for any pecuniary interest.
Astera Labs, Inc. General Counsel and Secretary Philip Mazzara reported automatic sales of company stock tied to tax withholding. On May 18, 2026, he sold a total of 14,076 shares of Astera Labs common stock in open-market transactions.
According to the footnotes, these shares were required to be sold to satisfy tax withholding obligations from the vesting and settlement of previously granted restricted stock units. The company had elected in advance to use a “sell to cover” method, so the trades were automatic rather than discretionary. The shares were sold at weighted-average prices within ranges that span from about $216.10 to $235.94 per share.